Industry reports
Editor highlights

Publication dates

All regions

data types

Growth Hormone Market and Forecasts, April 2014

You might be interested in: biosimilar, biopharmaceutical, dairy farming, more »


 
1-10 of about 200 reports for Growth Hormone

Growth Hormone Sector in The United States

  • Industry report
  • March 2012
  • 11 pages

... When first created, ghrh11002/h11002 mice were named laron mice, because they seemed to share common cause and defects that include deficiency in growth hormone signaling and congenital igf ...

Biopharmaceutical Market (biopharmaceutical, growth hormone, biogeneric) in Australia, China and India

  • Industry report
  • March 2012
  • 2 pages
  • by Corporation

... Gen focuses in the areas of gastroenterology, endocrinology and immunology. Its product portfolio includes therapeutics such as rhuman growth hormone, rhuman insulin and gcsf. Scigen has acquired the rights ...

Biopharmaceutical Sector (biopharmaceutical, growth hormone, biogeneric) in Australia, China and India

  • Industry report
  • March 2012
  • 2 pages

... Gen focuses in the areas of gastroenterology, endocrinology and immunology. Its product portfolio includes therapeutics such as rhuman growth hormone, rhuman insulin and gcsf. Scigen has acquired the rights ...

Biopharmaceutical Business (biopharmaceutical, growth hormone, biogeneric) in Australia, India and Singapore

  • Industry report
  • June 2012
  • 2 pages

... Of gastroenterology, endocrinology and immunology. Its product portfolio includes therapeutics such as rhuman growth hormone, rhuman insulin and gcsf. Scigen has acquired the rights to manufacture, distribute ...

Biopharmaceutical Industry (biopharmaceutical, growth hormone) in Australia, Singapore and India

  • Industry report
  • June 2012
  • 2 pages

... Portfolio includes therapeutics such as rhuman growth hormone, rhuman insulin and gcsf. ______________________________________________________________________ Scigen limited arbn 101 318 852 suite 1, 13b ...

The Australian Biopharmaceutical Industry Brief (biopharmaceutical, interferon alpha, growth hormone)

  • Industry report
  • January 2012
  • 2 pages
  • by Corporation

... Therapeutics such as rhuman growth hormone, rhuman insulin, gcsf and interferon alpha 2b. For personal use only ______________________________________________________________________ scigen limited arbn 101 ...

Biosimilar Sector in Europe

  • Industry report
  • September 2013
  • 16 pages

... In this review we provide an overview of data related to switching between human recombinant growth hormones, erythropoietins and granulocyte colony stimulating agents. We reviewed data from clinical trials ...

Biosimilar Market in Europe

  • Industry report
  • September 2013
  • 16 pages

... In this review we provide an overview of data related to switching between human recombinant growth hormones, erythropoietins and granulocyte colony stimulating agents. We reviewed data from clinical trials ...

The Australian Biopharmaceutical Industry Brief (biopharmaceutical, hepatitis b vaccine, interferon alpha)

  • Industry report
  • January 2012
  • 2 pages
  • by Corporation

... Hepatitis b vaccine and therapeutics such as rhuman growth hormone, rhuman insulin, gcsf and interferon alpha 2b. Scigen has acquired the rights to manufacture, distribute and market biopharmaceutical ...

Biopharmaceutical in Iran : Innovation and Technology Trends

  • Industry report
  • August 2012
  • 6 pages

... Active raw materials as imported materials. Human growth hormones and insu- lin are two major ones. Biopharmaceutical products are among the most expensive medicines available in the market. Monoclonal ...

» Purchase Premium Reports (From $ 250 - $ 10 000)

35 reports for Growth Hormone
Prolor Biotech, Inc. (PBTH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Prolor Biotech, Inc. (PBTH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

Summary PROLOR Biotech, Inc. (Prolor), formerly Modigene Inc., is a development stage biopharmaceutical company. It focuses on developing longer-lasting, proprietary versions of already approved therapeutic ...


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.